Pedal Pump Clinical Trial on Edema V1
David McVay · NCT07760363
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 60
- US sites recruiting
- 1
- Study start
- August 6, 2026
- Record last updated
- August 12, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Previous research on the osteopathic manual technique entitled "Pedal Pump" has shown health benefits, specifically increasing lymphatic flow, decreasing lower extremity edema, and decreasing serum lactic acid after maximal exercise. However, due to the limitation of human practitioners, research has been limited.
The Pedal Pump is now a device which facilitates consistency in treatment and allows for increased sample size in research. This clinical trial studies the effects of 10 minutes of Pedal Pump treatment for hospitalized patients with lower extremity edema.
Key Question for this first study: Is the Pedal Pump a feasible treatment for hospitalized patients? Secondary question: Does the Pedal Pump decrease lower extremity edema?
This is a novel idea in its early stage of development, so Investigators anticipate product advancements, further testing with larger population sizes, and future publications.
Being studied: Pedal Pump; Pedal Pump Sham
Conditions: Lower Extremity Edema; Congestive Heart Failure(CHF); Chronic Venous Insufficiency (CVI); Kidney Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Bilateral lower extremity edema of at least mild severity judged by the treating clinician to be due to CHF, chronic venous insufficiency, kidney disease, or other etiologies of fluid overload conditions.
- Medically stable
- Able to remain in Fowler position for 10 minutes
- Patients in the ER, observation, or admitted to the hospital for any period of time; outpatients (specifically CHF clinic patients)
- Patients must give informed consent to participate. The patient must be able to read the consent form (in English or Spanish) or give consent after the form is translated for the patient.
Exclusion Criteria
- Patients using a hospital bed which has the scale on the foot board
- Lymphedema (interstitial protein-built fluid)
- Lipedema (fat distribution)
- Pressure ulcers
- Active DVT (i.e. Patients who have signs of acute unilateral swelling must have a documented negative lower extremity venous duplex ultrasound within the current admission before they will be included in the trial.)
- Symptomatic peripheral vascular disease
- Wounds or infections in the feet, legs, buttocks, or back
- Weeping lymphedema or bullous cellulitis
- Uncontrolled hypertension (BP>180/110) in the recent 2 hours
- Uncontrolled hypotension (BP \<80/45) in the recent 2 hours
- Heart rate greater than 110 or less than 45 in the recent 2 hours
- Leg or back surgery in previous 30 days
- Known pregnancy
- Severe osteoporosis/fracture risk
Recruiting US locations
Hillcrest Medical Center
Tulsa, OK 74104
Site contact: Dorene Taqi · 9185791072 · dorene.taqi@hillcrest.com
Study contacts (from the official record)
- David W McVay, DO · 918-376-0107 · davidwilliammcvay@gmail.com
- Dorene Taqi · 918-579-1072 · dorene.taqi@hillcrest.com
Similar studies in Oklahoma
All heart & blood pressure studies in Oklahoma →- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Tulsa, OK + 64 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
VisCardia Inc.
- Location
- Tulsa, OK + 3 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated…
Pulnovo Medical, Inc.
- Location
- Tulsa, OK + 12 other US sites
- Eligibility basics
- Ages 18–85
- Recruiting
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Supira Medical
- Location
- Tulsa, OK + 24 other US sites
- Eligibility basics
- Ages 18–90